Description

Eloralintide  – Selective Amylin Receptor Agonist Reference Material

Elora is a novel, long-acting synthetic peptide engineered as a highly selective amylin receptor agonist. Formulated with a C20 fatty diacid moiety for extended pharmacokinetic half-life, it is widely investigated in advanced preclinical and laboratory research for its targeted activation of amylin receptor subtypes (AMY1R/AMY3R). Research models evaluate Eloralintide for its mechanisms in homeostatic appetite regulation, food intake suppression, gastric motility modulation, and preferential reduction of fat mass while maintaining targeted cellular metabolic stability.

Research-Only Use This material is strictly intended for laboratory research and laboratory analytical purposes only. It is not intended for human consumption, clinical diagnostic procedures, or veterinary administration. No claims are made regarding its safety, efficacy, or therapeutic applicability.

Disclaimer The information provided is curated strictly for scientific education and research reference. It is not intended to diagnose, treat, cure, or prevent any disease. This product has not been evaluated or approved by the FDA or any equivalent regulatory agency.

Terms of Sale By purchasing this item, you confirm that you are a qualified researcher, institution, or laboratory operating in full compliance with all applicable local, state, and federal regulations. The seller assumes no liability for misuse, improper handling, unauthorized application, or unlawful distribution, and shall not be responsible for any resulting loss, injury, claim, or damage.